These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38497988)

  • 1. Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.
    Unemo M; Golparian D; Oxelbark J; Kong FYS; Brown D; Louie A; Drusano G; Jacobsson S
    J Antimicrob Chemother; 2024 May; 79(5):1006-1013. PubMed ID: 38497988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
    Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M
    BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
    Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
    APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.
    Unemo M
    BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating
    Jacobsson S; Golparian D; Oxelbark J; Wicha WW; da Costa RMA; Franceschi F; Brown D; Louie A; Gelone SP; Drusano G; Unemo M
    Front Pharmacol; 2022; 13():1035841. PubMed ID: 36452226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
    Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
    BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X
    Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance and molecular epidemiological typing of Neisseria gonorrhoeae isolates from Kyrgyzstan in Central Asia, 2012 and 2017.
    Karymbaeva S; Boiko I; Jacobsson S; Mamaeva G; Ibraeva A; Usupova D; Golparian D; Unemo M
    BMC Infect Dis; 2021 Jun; 21(1):559. PubMed ID: 34118893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
    BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility in
    Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
    Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between In vitro susceptibility and treatment outcome with azithromycin in gonorrhoea: a prospective study.
    Khaki P; Bhalla P; Sharma A; Kumar V
    Indian J Med Microbiol; 2007 Oct; 25(4):354-7. PubMed ID: 18087084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea.
    Unemo M; Golparian D; Eyre DW
    Methods Mol Biol; 2019; 1997():37-58. PubMed ID: 31119616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against
    Jacobsson S; Golparian D; Oxelbark J; Alirol E; Franceschi F; Gustafsson TN; Brown D; Louie A; Drusano G; Unemo M
    Front Pharmacol; 2021; 12():682135. PubMed ID: 34093206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
    Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
    J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial-resistant gonorrhoea: the national public health response, England, 2013 to 2020.
    Merrick R; Cole M; Pitt R; Enayat Q; Ivanov Z; Day M; Sun S; Sinka K; Woodford N; Mohammed H; Fifer H
    Euro Surveill; 2022 Oct; 27(40):. PubMed ID: 36205171
    [No Abstract]   [Full Text] [Related]  

  • 18. First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020.
    Al-Maslamani M; Elmagboul EBI; Puthiyottil A; Chemaitelly H; Varghese MK; Al Romaihi HE; Al-Thani MH; Al Khal A; Unemo M; Abu-Raddad LJ
    PLoS One; 2022; 17(3):e0264737. PubMed ID: 35235608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.
    Brunner A; Nemes-Nikodem E; Mihalik N; Marschalko M; Karpati S; Ostorhazi E
    BMC Infect Dis; 2014 Aug; 14():433. PubMed ID: 25098185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against
    Jacobsson S; Golparian D; Oxelbark J; Kong FYS; Da Costa RMA; Franceschi F; Brown D; Louie A; Drusano G; Unemo M
    Front Pharmacol; 2023; 14():1291885. PubMed ID: 38130409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.